Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Microvast Holdings (MVSTW) Research & Development (2020 - 2025)

Microvast Holdings has reported Research & Development over the past 6 years, most recently at $10.4 million for Q4 2025.

  • Quarterly results put Research & Development at $10.4 million for Q4 2025, up 18.36% from a year ago — trailing twelve months through Dec 2025 was $34.1 million (down 16.94% YoY), and the annual figure for FY2025 was $34.1 million, down 16.94%.
  • Research & Development for Q4 2025 was $10.4 million at Microvast Holdings, up from $7.8 million in the prior quarter.
  • Over the last five years, Research & Development for MVSTW hit a ceiling of $13.5 million in Q3 2021 and a floor of $3.8 million in Q1 2021.
  • Median Research & Development over the past 5 years was $10.4 million (2022), compared with a mean of $9.9 million.
  • Biggest five-year swings in Research & Development: skyrocketed 198.71% in 2022 and later decreased 28.23% in 2025.
  • Microvast Holdings' Research & Development stood at $11.2 million in 2021, then dropped by 6.15% to $10.5 million in 2022, then grew by 8.54% to $11.4 million in 2023, then dropped by 23.0% to $8.8 million in 2024, then grew by 18.36% to $10.4 million in 2025.
  • The last three reported values for Research & Development were $10.4 million (Q4 2025), $7.8 million (Q3 2025), and $7.7 million (Q2 2025) per Business Quant data.